Canada - English - Health Canada

bristol-myers squibb canada - pomalidomide - capsule - 1mg - pomalidomide 1mg - antineoplastic agents

Canada - English - Health Canada

bristol-myers squibb canada - pomalidomide - capsule - 2mg - pomalidomide 2mg - antineoplastic agents

Canada - English - Health Canada

bristol-myers squibb canada - pomalidomide - capsule - 3mg - pomalidomide 3mg - antineoplastic agents

Canada - English - Health Canada

bristol-myers squibb canada - pomalidomide - capsule - 4mg - pomalidomide 4mg - antineoplastic agents

Israel - English - Ministry of Health

neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 1 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide

Israel - English - Ministry of Health

neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 2 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide

Israel - English - Ministry of Health

neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 3 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide.

Israel - English - Ministry of Health

neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 4 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide.

Canada - English - Health Canada

natco pharma (canada) inc - pomalidomide - capsule - 1mg - pomalidomide 1mg

Canada - English - Health Canada

natco pharma (canada) inc - pomalidomide - capsule - 2mg - pomalidomide 2mg